spacer
spacer

PDBsum entry 2ooa

Go to PDB code: 
protein Protein-protein interface(s) links
Ligase PDB id
2ooa

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
42 a.a. *
Waters ×130
* Residue conservation analysis
PDB id:
2ooa
Name: Ligase
Title: Crystal structure of the uba domain from cbl-b ubiquitin ligase
Structure: E3 ubiquitin-protein ligase cbl-b. Chain: a, b. Fragment: uba domain. Synonym: signal transduction protein cbl-b, sh3-binding protein cbl- b, casitas b-lineage lymphoma proto-oncogene b, ring finger protein 56. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: cblb, rnf56. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693.
Resolution:
1.56Å     R-factor:   0.206     R-free:   0.240
Authors: G.Kozlov,K.Gehring
Key ref:
P.Peschard et al. (2007). Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b. Mol Cell, 27, 474-485. PubMed id: 17679095 DOI: 10.1016/j.molcel.2007.06.023
Date:
25-Jan-07     Release date:   06-Feb-07    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q13191  (CBLB_HUMAN) -  E3 ubiquitin-protein ligase CBL-B from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
982 a.a.
42 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.2.3.2.27  - RING-type E3 ubiquitin transferase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N6- ubiquitinyl-[acceptor protein]-L-lysine

 

 
DOI no: 10.1016/j.molcel.2007.06.023 Mol Cell 27:474-485 (2007)
PubMed id: 17679095  
 
 
Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b.
P.Peschard, G.Kozlov, T.Lin, I.A.Mirza, A.M.Berghuis, S.Lipkowitz, M.Park, K.Gehring.
 
  ABSTRACT  
 
Cbl proteins are E3 ubiquitin ligases that are negative regulators of many receptor tyrosine kinases. Cbl-b and c-Cbl contain a ubiquitin-associated (UBA) domain, which is present in a variety of proteins involved in ubiquitin-mediated processes. Despite high sequence identity, Cbl UBA domains display remarkably different ubiquitin-binding properties. Here, we report the crystal structure of the UBA domain of Cbl-b in complex with ubiquitin at 1.9 A resolution. The structure reveals an atypical mechanism of ubiquitin recognition by the first helix of the UBA. Helices 2 and 3 of the UBA domain form a second binding surface, which mediates UBA dimerization in the crystal and in solution. Site-directed mutagenesis demonstrates that Cbl-b dimerization is regulated by ubiquitin binding and required for tyrosine phosphorylation of Cbl-b and ubiquitination of Cbl-b substrates. These studies demonstrate a role for ubiquitin in regulating biological activity by promoting protein dimerization.
 
  Selected figure(s)  
 
Figure 2.
Figure 2. Ubiquitin Binding to the UBA Domain of Cbl-b Is Required for Cbl-b Biological Activity
(A and B) Amino acid residues Ala937 (A937), Met940 (M940), and Phe946 (F946) in the UBA domain of Cbl-b are required for binding to ubiquitin. (A) In vitro binding of GST-UBA[b] to ubiquitin agarose. Wild-type and mutant proteins bound to ubiquitin (Ub-agarose) or in the input (Input lysate, 5%) were resolved by SDS-PAGE and detected by immunoblotting with an antibody against GST. (B) In vitro binding to ubiquitin chains. Wild-type or mutant GST-UBA[b] was immobilized on glutathione Sepharose beads and incubated with either Lys48 (K48)- or Lys63 (K63)-linked ubiquitin chains. Following elution, bound ubiquitin chains were detected with an anti-ubiquitin antibody (IB Ub). As a control, GST-UBA[b] from the beads was visualized by staining (Coomassie).
(C and D) Deletion or mutation of UBA[b] decreases the phosphorylation of Cbl-b following Met receptor activation. HeLa cells were transfected with wild-type HA-Cbl-b or mutants unable to bind ubiquitin (A397E, M940A, F946A, and ΔUBA). Following stimulation with HGF for the indicated time, HA-Cbl-b proteins were immunoprecipitated and detected with an anti-phosphotyrosine antibody (IB pTyr) or an anti-HA antibody (IB HA). The graphs (right) represent the quantification of immunoblots from four (C) or two (D) independent experiments. The degree of tyrosine phosphorylation of Cbl-b was calculated as the ratio of anti-pTyr over anti-HA immunostaining, normalized for the wild-type at 10 min, and averaged with standard deviations shown.
(E) Deletion or mutation of the Cbl-b UBA domain decreases Met receptor ubiquitination. HEK293 cells were transfected with empty vector, wild-type HA-Cbl-b, two mutants unable to bind ubiquitin (ΔUBA and A937E), or a mutant with no ubiquitin-ligase activity (C373A). After 24 hr, cellular proteins were immunoprecipitated with an anti-Met antibody (IP Met) and probed with antibodies against ubiquitin (IB ubiquitin) or Met receptor (IB Met). The total amount of transfected protein was determined in a whole-cell lysate (WCL) with an anti-HA antibody (IB HA Cbl-b). The graph (right) presents the degree of ubiquitination plotted as the normalized ratio of anti-Ub over anti-Met immunostaining from two independent experiments.
Figure 5.
Figure 5. Ubiquitin Chains Promote the Dimerization of Cbl-b
(A) Model of tetraubiquitin bound to the UBA[b] dimer. The structure of the UBA dimer (yellow) with two ubiquitin molecules bound (purple) from the X-ray crystal structure is shown with two bridging ubiquitin molecules (pink) added to show how the UBA dimer could bind Lys48-linked ubiquitin chains. The C-terminal Leu-Arg-Gly-Gly ubiquitin tails are disordered in solution and depicted by single-letter amino acid codes.
(B) Ubiquitin chains promote the dimerization of the Cbl-b. HEK293 cells were cotransfected with Flag-tagged Cbl-b wild-type and HA-tagged Cbl-b wild-type or a mutant that does not bind ubiquitin (A937E). Flag-tagged Cbl-b was immunoprecipitated and resolved by SDS-PAGE. The presence of HA-Cbl-b proteins in the immunoprecipitate was detected by western blotting. Where indicated, hexaubiquitin chains were added to the lysates 30 min prior to the immunoprecipitations. At the end of the immunoprecipitations, aliquots of the lysates were resolved by SDS-PAGE and immunoblotted with anti-HA and anti-ubiquitin antibodies to detect the presence of the HA-Cbl-b proteins and ubiquitin chains, respectively.
(C and D) Isothermal calorimetric titrations of the UBA domain from Cbl-b with ubiquitin (C) and Lys48-linked tetraubiquitin (D). Each panel shows the thermogram (top) and data analysis after integration (bottom). The experimental data (rectangles) were fit (thin line) to a model of a single binding site, and the values of affinity, stoichiometry, ΔH, and error estimates in the fitting were reported.
(E and F) Dimerization of UBA[b] is required for its association with ubiquitin chains, but not with monoubiquitin. (E) In vitro binding to ubiquitin agarose. Wild-type and mutant GST-UBA[b] proteins bound to ubiquitin (Ub-agarose) or in the input (Input lysate, 5%) were detected by immunoblotting with an antibody against GST. (F) In vitro binding to ubiquitin chains. Wild-type or mutant GST-UBA proteins were immobilized on glutathione Sepharose beads and incubated with Lys48 (K48)-linked ubiquitin chains. The bound ubiquitin chains were detected with an anti-ubiquitin antibody (IB Ub) and GST-UBA with anti-GST antibody (IB GST).
 
  The above figures are reprinted by permission from Cell Press: Mol Cell (2007, 27, 474-485) copyright 2007.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
22266821 H.Dou, L.Buetow, A.Hock, G.J.Sibbet, K.H.Vousden, and D.T.Huang (2012).
Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl.
  Nat Struct Mol Biol, 19, 184-192.
PDB codes: 2y1m 2y1n 4a49 4a4b 4a4c
21332354 J.H.Hurley, and H.Stenmark (2011).
Molecular mechanisms of ubiquitin-dependent membrane traffic.
  Annu Rev Biophys, 40, 119-142.  
21432937 K.Y.Huang, G.A.Amodeo, L.Tong, and A.McDermott (2011).
The structure of human ubiquitin in 2-methyl-2,4-pentanediol: a new conformational switch.
  Protein Sci, 20, 630-639.
PDB code: 3ons
21397182 P.Mitra, and D.Pal (2011).
Combining Bayes classification and point group symmetry under Boolean framework for enhanced protein quaternary structure inference.
  Structure, 19, 304-312.  
20399133 H.Fu, Y.L.Lin, and A.S.Fatimababy (2010).
Proteasomal recognition of ubiquitylated substrates.
  Trends Plant Sci, 15, 375-386.  
19109251 C.A.Parachoniak, and M.Park (2009).
Distinct Recruitment of Eps15 via Its Coiled-coil Domain Is Required For Efficient Down-regulation of the Met Receptor Tyrosine Kinase.
  J Biol Chem, 284, 8382-8394.  
19373254 D.Komander, F.Reyes-Turcu, J.D.Licchesi, P.Odenwaelder, K.D.Wilkinson, and D.Barford (2009).
Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains.
  EMBO Rep, 10, 466-473.
PDB codes: 2jf5 2w9n
19620964 J.J.Sims, A.Haririnia, B.C.Dickinson, D.Fushman, and R.E.Cohen (2009).
Avid interactions underlie the Lys63-linked polyubiquitin binding specificities observed for UBA domains.
  Nat Struct Mol Biol, 16, 883-889.  
19208803 Q.Y.Zhang, J.H.Mao, P.Liu, Q.H.Huang, J.Lu, Y.Y.Xie, L.Weng, Y.Zhang, Q.Chen, S.J.Chen, and Z.Chen (2009).
A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia.
  Proc Natl Acad Sci U S A, 106, 3378-3383.  
19465916 Q.Yin, S.C.Lin, B.Lamothe, M.Lu, Y.C.Lo, G.Hura, L.Zheng, R.L.Rich, A.D.Campos, D.G.Myszka, M.J.Lenardo, B.G.Darnay, and H.Wu (2009).
E2 interaction and dimerization in the crystal structure of TRAF6.
  Nat Struct Mol Biol, 16, 658-666.
PDB codes: 3hcs 3hct 3hcu
19489726 Z.Lu, and T.Hunter (2009).
Degradation of activated protein kinases by ubiquitination.
  Annu Rev Biochem, 78, 435-475.  
18827983 D.L.Gay, H.Ramón, and P.M.Oliver (2008).
Cbl- and Nedd4-family ubiquitin ligases: balancing tolerance and immunity.
  Immunol Res, 42, 51-64.  
18542056 M.A.Stutz, D.L.Shattuck, M.B.Laederich, K.L.Carraway, and C.Sweeney (2008).
LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII.
  Oncogene, 27, 5741-5752.  
18931663 M.Gyrd-Hansen, M.Darding, M.Miasari, M.M.Santoro, L.Zender, W.Xue, T.Tenev, P.C.da Fonseca, M.Zvelebil, J.M.Bujnicki, S.Lowe, J.Silke, and P.Meier (2008).
IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis.
  Nat Cell Biol, 10, 1309-1317.  
18596201 Z.R.Zhou, H.C.Gao, C.J.Zhou, Y.G.Chang, J.Hong, A.X.Song, D.H.Lin, and H.Y.Hu (2008).
Differential ubiquitin binding of the UBA domains from human c-Cbl and Cbl-b: NMR structural and biochemical insights.
  Protein Sci, 17, 1805-1814.
PDB codes: 2jnh 2juj
17897937 G.Kozlov, L.Nguyen, T.Lin, G.De Crescenzo, M.Park, and K.Gehring (2007).
Structural basis of ubiquitin recognition by the ubiquitin-associated (UBA) domain of the ubiquitin ligase EDD.
  J Biol Chem, 282, 35787-35795.
PDB code: 2qho
17635922 G.Kozlov, P.Peschard, B.Zimmerman, T.Lin, T.Moldoveanu, N.Mansur-Azzam, K.Gehring, and M.Park (2007).
Structural basis for UBA-mediated dimerization of c-Cbl ubiquitin ligase.
  J Biol Chem, 282, 27547-27555.
PDB code: 2oo9
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer